Filing Details
- Accession Number:
- 0001461959-17-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-14 11:36:44
- Reporting Period:
- 2017-03-29
- Filing Date:
- 2017-04-14
- Accepted Time:
- 2017-04-14 11:36:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1596062 | Q Biomed Inc. | QBIO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1461959 | S William Rosenstadt | Ortoli Rosenstadt Llp 501 Madison Avenue, 14Th Floor New York NY 10022 | General Counsel | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-03-29 | 4,400 | $5.29 | 980,549 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-03-30 | 5,000 | $7.60 | 975,549 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on January 17, 2017 for the sale of up to 92,000 shares of common stock. Such sales were outside of the holder's investment decision.